$HAE
HAEMONETICS CORP Stock $hae

$hae Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000031314317000009 Filed on February 06, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2015 Q4
Revenue		$227.8M	$233.4M
YoY Change		-2.38%	0.67%
Cost Of Revenue		$126.8M	$124.5M
YoY Change		1.79%	3.63%
Gross Profit		$101.1M	$108.9M
YoY Change		-7.14%	-2.51%
Gross Profit Margin		44.36%	46.64%
Selling, General & Admin		$71.41M	$78.94M
YoY Change		-9.55%	-4.33%
% of Gross Profit		70.64%	72.52%
Research & Development		$8.462M	$10.94M
YoY Change		-22.66%	2.81%
% of Gross Profit		8.37%	10.05%
Depreciation & Amortization		$22.80M	$22.70M
YoY Change		0.44%	1.79%
% of Gross Profit		22.56%	20.85%
Operating Expenses		$79.87M	$170.0M
YoY Change		-53.03%	82.05%
Operating Profit		$21.21M	-$61.18M
YoY Change		-134.67%	-435.03%
Interest Expense		-$2.000M	-$2.100M
YoY Change		-4.76%	-8.7%
% of Operating Profit		-9.43%
Other Income/Expense, Net		-$2.275M	-$2.141M
YoY Change		6.26%	-7.24%
Pretax Income		$18.94M	-$63.32M
YoY Change		-129.91%	-496.93%
Income Tax		$3.500M	-$3.878M
% Of Pretax Income		18.48%
Net Earnings		$15.39M	-$59.44M
YoY Change		-125.9%	-471.78%
Net Earnings / Revenue		6.76%	-25.47%
Basic Earnings Per Share		$0.30	-$1.17
Diluted Earnings Per Share		$0.30	-$1.17
COMMON SHARES
Basic Shares Outstanding	52.00M shares	51.71M shares	50.74M shares
Diluted Shares Outstanding		52.10M shares	50.74M shares

Balance Sheet

Concept	2016 Q4	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$138.9M	$105.2M
YoY Change	32.03%	-15.97%
Cash & Equivalents	$129.6M	$105.2M
Short-Term Investments
Other Short-Term Assets	$27.40M	$43.60M
YoY Change	-37.16%	-36.35%
Inventory	$188.5M	$203.9M
Prepaid Expenses
Receivables	$150.6M	$148.8M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$496.6M	$501.4M
YoY Change	-0.96%	-8.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$336.0M	$332.8M
YoY Change	0.96%	2.87%
Goodwill	$267.3M	$266.9M
YoY Change	0.14%	-20.31%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.59M	$15.24M
YoY Change	-10.87%	12.24%
Total Long-Term Assets	$809.9M	$835.1M
YoY Change	-3.02%	-9.66%
TOTAL ASSETS
Total Short-Term Assets	$496.6M	$501.4M
Total Long-Term Assets	$809.9M	$835.1M
Total Assets	$1.306B	$1.336B
YoY Change	-2.24%	-9.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$48.85M	$39.64M
YoY Change	23.24%	-15.36%
Accrued Expenses	$40.80M	$38.20M
YoY Change	6.81%	-20.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$66.27M	$46.29M
YoY Change	43.16%	497.48%
Total Short-Term Liabilities	$216.2M	$175.3M
YoY Change	23.32%	6.69%
LONG-TERM LIABILITIES
Long-Term Debt	$270.0M	$380.8M
YoY Change	-29.1%	-9.55%
Other Long-Term Liabilities	$24.84M	$27.21M
YoY Change	-8.71%	-6.23%
Total Long-Term Liabilities	$294.8M	$408.0M
YoY Change	-27.74%	-9.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$216.2M	$175.3M
Total Long-Term Liabilities	$294.8M	$408.0M
Total Liabilities	$511.1M	$583.4M
YoY Change	-12.39%	-5.05%
SHAREHOLDERS EQUITY
Retained Earnings	$341.1M	$324.9M
YoY Change	4.97%	-23.29%
Common Stock	$468.9M	$436.0M
YoY Change	7.54%	4.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$770.9M	$719.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.306B	$1.336B
YoY Change	-2.24%	-9.34%

Cashflow Statement

Concept	2016 Q4	2015 Q4
OPERATING ACTIVITIES
Net Income	$15.39M	-$59.44M
YoY Change	-125.9%	-471.78%
Depreciation, Depletion And Amortization	$22.80M	$22.70M
YoY Change	0.44%	1.79%
Cash From Operating Activities	$39.30M	$31.80M
YoY Change	23.58%	18.22%
INVESTING ACTIVITIES
Capital Expenditures	-$19.10M	-$23.80M
YoY Change	-19.75%	-19.59%
Acquisitions
YoY Change
Other Investing Activities	$100.0K	$100.0K
YoY Change	0.0%
Cash From Investing Activities	-$19.00M	-$23.70M
YoY Change	-19.83%	-19.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	400.0K	-3.000M
YoY Change	-113.33%	1400.0%
NET CHANGE
Cash From Operating Activities	39.30M	31.80M
Cash From Investing Activities	-19.00M	-23.70M
Cash From Financing Activities	400.0K	-3.000M
Net Change In Cash	20.70M	5.100M
YoY Change	305.88%	-275.86%
FREE CASH FLOW
Cash From Operating Activities	$39.30M	$31.80M
Capital Expenditures	-$19.10M	-$23.80M
Free Cash Flow	$58.40M	$55.60M
YoY Change	5.04%	-1.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-01
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0000313143
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	52004300	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	HAEMONETICS CORP
	hae	Capitalized Software Development Costs Placedinto Service CapitalizedSoftwareDevelopmentCostsPlacedintoService	6400000	USD
	hae	Capitalized Software Development Costs Placedinto Service CapitalizedSoftwareDevelopmentCostsPlacedintoService	4500000	USD
CY2016Q4	hae	Effective Income Tax Rate Reconciliation Tax Benefit Impairment Losses Amount EffectiveIncomeTaxRateReconciliationTaxBenefitImpairmentLossesAmount	7100000	USD
	hae	Effective Income Tax Rate Reconciliation Tax Benefit Impairment Losses Amount EffectiveIncomeTaxRateReconciliationTaxBenefitImpairmentLossesAmount	7100000	USD
CY2015Q4	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-1179000	USD
	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	1367000	USD
CY2016Q4	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-5397000	USD
	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-8617000	USD
CY2015Q4	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	7000	USD
	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	-3875000	USD
CY2016Q4	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	151000	USD
	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	790000	USD
	hae	General Warranty Period On Parts And Labor GeneralWarrantyPeriodOnPartsAndLabor	P1Y
CY2015Q4	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	234563000	USD
	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	665123000	USD
CY2016Q4	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	233238000	USD
	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	666667000	USD
CY2016Q4	hae	Numberof Franchises NumberofFranchises	4	franchise
CY2016Q4	hae	Restructuring Charges Payable In Next Twelve Months RestructuringChargesPayableInNextTwelveMonths	9200000	USD
CY2015Q4	hae	Restructuring Related Costs RestructuringRelatedCosts	4520000	USD
CY2016Q4	hae	Restructuring Related Costs RestructuringRelatedCosts	4706000	USD
	hae	Restructuring Related Costs RestructuringRelatedCosts	9087000	USD
	hae	Restructuring Related Costs RestructuringRelatedCosts	11605000	USD
CY2016Q4	hae	Restructuringand Related Cost Expected Savings RestructuringandRelatedCostExpectedSavings	40000000	USD
	hae	Unrecognized Tax Benefits Decreases Resultingfrom Lapseof Applicable Statuteof Limitations UnrecognizedTaxBenefitsDecreasesResultingfromLapseofApplicableStatuteofLimitations	500000	USD
	hae	Unrecognized Tax Benefits Increase Resultingfrom Potential Tax Impactsof Restructuring UnrecognizedTaxBenefitsIncreaseResultingfromPotentialTaxImpactsofRestructuring	1300000	USD
CY2015Q4	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	8386000	USD
	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	29854000	USD
CY2016Q4	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	6738000	USD
	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	27151000	USD
CY2015Q4	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	8570000	USD
	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	29746000	USD
CY2016Q4	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	6762000	USD
	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	27215000	USD
CY2015Q4	hae	Statutory Capital Gains Tax Rate StatutoryCapitalGainsTaxRate	0.15
CY2016Q2	hae	Statutory Capital Gains Tax Rate StatutoryCapitalGainsTaxRate	0.20
	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	9259000	USD
	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	5081000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	39674000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	48848000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	157093000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	150557000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-35040000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-39025000	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	439912000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	468348000	USD
CY2015Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7389000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	22193000	USD
CY2016Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6530000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20611000	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2253000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2656000	USD
CY2016Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1700000	shares
CY2015Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	85048000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	85048000	USD
CY2016Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	210000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1525000	USD
CY2016Q2	us-gaap	Assets Assets	1319128000	USD
CY2016Q4	us-gaap	Assets Assets	1306421000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	488086000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	496562000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4898000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4727000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	1300000	USD
CY2016Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	54900000	USD
CY2016Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	61900000	USD
	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	3560000	USD
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	14400000	USD
CY2016Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	16900000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160662000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105167000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	115123000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	129639000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-55495000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14516000	USD
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50932348	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51825961	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50932348	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51825961	shares
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	509000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	518000	USD
CY2015Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-62316000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-66469000	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13084000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20888000	USD
CY2015Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	124529000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	349799000	USD
CY2016Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	126762000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	361667000	USD
CY2016Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	1300000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7088000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	7055000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	7575000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	21377000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	24463000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67721000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67531000	USD
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.92
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.92
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-662000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1937000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	9000000	USD
CY2015Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.061
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.038
CY2016Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.187
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	35798000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	41556000	USD
	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	4340000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	190816000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	206444000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	204458000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	185427000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	267840000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	267314000	USD
CY2015Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	85048000	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	85048000	USD
CY2016Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	449000	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1384000	USD
CY2016Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	66300000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	66300000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	108855000	USD
	us-gaap	Gross Profit GrossProfit	316691000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	101079000	USD
	us-gaap	Gross Profit GrossProfit	296383000	USD
CY2016Q4	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	18700000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	18700000	USD
CY2016Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	400000	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1900000	USD
CY2015Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-63318000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-45148000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18937000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	31711000	USD
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3900000	USD
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3878000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1696000	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3544000	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6839000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5884000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5724000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-39971000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20333000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4186000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3878000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2791000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13960000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6622000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	996000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-997000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-868000	USD
	us-gaap	Interest Paid Net InterestPaidNet	6206000	USD
	us-gaap	Interest Paid Net InterestPaidNet	6058000	USD
CY2016Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	111786000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	121558000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	187028000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	188489000	USD
CY2016Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	62062000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	56729000	USD
CY2016Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13180000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10202000	USD
CY2016Q4	us-gaap	Inventory Write Down InventoryWriteDown	4500000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1319128000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1306421000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	185551000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	216221000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	337200000	USD
CY2016Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	43471000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	66271000	USD
CY2016Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	364529000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	269997000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-46971000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-49964000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76474000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58744000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	68612000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	125161000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-59440000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-46844000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	15393000	USD
	us-gaap	Net Income Loss NetIncomeLoss	24872000	USD
CY2016	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	170032000	USD
	us-gaap	Operating Expenses OperatingExpenses	355083000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	79867000	USD
	us-gaap	Operating Expenses OperatingExpenses	258258000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-61177000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38392000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	21212000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	38125000	USD
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	85048000	USD
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	3413000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14055000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13586000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-8663000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3985000	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	66608000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	59546000	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26106000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24843000	USD
CY2015Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2141000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6756000	USD
CY2016Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2275000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6414000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	862000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	885000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	3000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	60984000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	16764000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	73871000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	60517000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28842000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27877000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	7143000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-40975000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	397000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1773000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10489000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	18278000	USD
CY2015Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	531000	USD
CY2015Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	362000	USD
CY2016Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	420000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	203000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	701000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1077000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	532000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	860000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	337634000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	335957000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	4055000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	11398000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-4678000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7114000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	30827000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	845000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10942000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33816000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8462000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28235000	USD
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	12900000	USD
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	8300000	USD
CY2016Q4	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	26000000	USD
CY2015Q4	us-gaap	Restructuring Charges RestructuringCharges	3866000	USD
	us-gaap	Restructuring Charges RestructuringCharges	18249000	USD
CY2016Q4	us-gaap	Restructuring Charges RestructuringCharges	2032000	USD
	us-gaap	Restructuring Charges RestructuringCharges	18064000	USD
CY2016Q2	us-gaap	Restructuring Reserve RestructuringReserve	8752000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	9453000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	599000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	316184000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	341056000	USD
CY2015Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	233384000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	666490000	USD
CY2016Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	227841000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	658050000	USD
CY2015Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	78940000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	240946000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	70956000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	228639000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6199000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6608000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	721565000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	770897000	USD
	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	1000000	USD
	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	1400000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2867000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-331000	USD
CY2015Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7070000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2523000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3380000	USD
	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	4158000	USD
	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	400000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	400000	USD
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	340000	USD
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1260000	USD
	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	729000	USD
	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	403000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	600000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1500000	USD
CY2015Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	395000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	302000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50741000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50927000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52103000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51671000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50741000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50927000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51708000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51369000	shares

Files In Submission

Name	View Source	Status
0000313143-17-000009-index-headers.html	Edgar Link	pending
0000313143-17-000009-index.html	Edgar Link	pending
0000313143-17-000009.txt	Edgar Link	pending
0000313143-17-000009-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hae-20161231.xml	Edgar Link	completed
hae-20161231.xsd	Edgar Link	pending
hae-20161231_cal.xml	Edgar Link	unprocessable
hae-20161231_def.xml	Edgar Link	unprocessable
hae-20161231_lab.xml	Edgar Link	unprocessable
hae-20161231_pre.xml	Edgar Link	unprocessable
haeq3dec2017doc.htm	Edgar Link	pending
haeq3dec2017ex311.htm	Edgar Link	pending
haeq3dec2017ex312.htm	Edgar Link	pending
haeq3dec2017ex321.htm	Edgar Link	pending
haeq3dec2017ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HAE
HAEMONETICS CORP Stock $hae

2017 Q1 Form 10-Q Financial Statement

#000031314317000009 Filed on February 06, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE HAEMONETICS CORP Stock $hae

2017 Q1 Form 10-Q Financial Statement

#000031314317000009 Filed on February 06, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE
HAEMONETICS CORP Stock $hae